al102
ayala pharmaceuticalsceuticals,novartis
['al102', 'pivotal', '$ayla']
$ayla presented interim data from ringside pivotal phase 2/3 trial of al102 show confirmed partial response in desmoid tumors, at esmo congress.
MAISA's Platform is based  MAISA's proprietary Optimization on Mathematical Probability Algorithm (OMPA) which derived majority from applied mathematics.